Document

Manufacturer of Controlled Substances; Notice of Registration

Department of Justice Drug Enforcement Administration By Notice dated May 12, 2000, and published in the Federal Register on June 2, 2000, ( 65 FR 35397 ), Sigma Aldrich Researc...

Department of Justice
Drug Enforcement Administration

By Notice dated May 12, 2000, and published in the Federal Register on June 2, 2000, (65 FR 35397), Sigma Aldrich Research Biochemicals, Inc., Attn: Richard Milius, 1-3 Strathmore Road, Natick, Massachusetts 01760, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below:

The firm plans to manufacture the listed controlled substances for laboratory reference standards and neurochemicals.

DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Sigma Aldrich Research Biochemicals, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Sigma Aldrich Research Biochemicals, Inc. on a regular basis to ensure that the company's continued registration is consistent with the public interest. These investigations have included ( printed page 57624) inspection and testing of the company's physical security systems, audits of the company's records, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted.

Drug Schedule
Cathinone (1235) I
Methcathinone (1237) I
Aminorex (1585) I
Alpha-Ethyltryptamine (7249) I
Lysergic acid diethylamide (7315) I
Tetrahydrocannabinols (7370) I
4-Bromo-2, 5-dimethoxyam- phetamine (7391) I
4-Bromo-2, 5-dimethoxyphen- ethylamine (7392) I
2, 5-Dimethoxyamphetamine (7396) I
3, 4-Methylendioxyamphetamine (7400) I
N-Hydroxy-3, 4-methylenedioxy- amphetamine (7402) I
3, 4-Methylenedioxy-N-ethylam- phetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405) I
Psilocybin (7437) I
1-[1- (2-Thienyl)cyclo- hexyl]piperidine (7470) I
Heroin (9200) I
Normorphine (9313) I
Amphetamine (1100) II
Methamphetamine (1105) II
Pentobarbital (2270) II
Phenylcyclohexylamine (7460) II
Phencyclidine (7471) II
Cocaine (9041) II
Codenine (9050) II
Diprenorphine (9058) II
Benzoylecgonine (9180) II
Levomethorphan (9210) II
Levorphanol (9220) II
Meperidine (9230) II
Metazocine (924) II
Methadone (9250) II
Morphine (9300) II
Thebaine (9333) II
Levo-alphacetylmethadol (LAAM) (9648) II
Fentanyl (9801) II

August 18, 2000.

John H. King,

Deputy Assistant Administrator Office of Diversion Control Drug Enforcement Administration.

[FR Doc. 00-24562 Filed 9-22-00; 8:45 am]

BILLING CODE 4410-09-M

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

65 FR 57623

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Manufacturer of Controlled Substances; Notice of Registration,” thefederalregister.org (September 25, 2000), https://thefederalregister.org/documents/00-24562/manufacturer-of-controlled-substances-notice-of-registration.